Cellular and humoral response after MRNA‐1273 SARS‐CoV‐2 vaccine in kidney transplant recipients

Author:

Cucchiari David12ORCID,Egri Natalia3,Bodro Marta4,Herrera Sabina4,Del Risco‐Zevallos Jimena1,Casals‐Urquiza Joaquim1,Cofan Frederic1,Moreno Asunción4,Rovira Jordi25ORCID,Banon‐Maneus Elisenda25,Ramirez‐Bajo Maria J.25,Ventura‐Aguiar Pedro12ORCID,Pérez‐Olmos Anna1,Garcia‐Pascual Marta1,Pascal Mariona367,Vilella Anna8,Trilla Antoni8,Ríos José910,Palou Eduard3,Juan Manel3,Bayés Beatriu1,Diekmann Fritz125ORCID

Affiliation:

1. Department of Nephrology and Kidney Transplantation Hospital Clínic Barcelona Spain

2. Laboratori Experimental de Nefrologia i Trasplantament (LENIT) Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain

3. Department of Immunology Hospital Clínic Barcelona Spain

4. Department of Infectious Diseases Hospital Clínic Barcelona Spain

5. Red de Investigación Renal (REDINREN) Madrid Spain

6. Immunoal·lergia Clínica Respiratoria i Experimental (IRCE) Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain

7. Red Nacional de Alergia, Asma, Reacciones Adversas y Alérgicas (ARADyAL) Instituto de Salud Carlos III (ISCIII) Madrid Spain

8. Department of Preventive Medicine and Epidemiology Hospital ClinicUniversitat de Barcelona Barcelona Spain

9. Medical Statistics Core Facility Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain

10. Biostatistics Unit Faculty of Medicine Universitat Autònoma de Barcelona Bellaterra Spain

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference25 articles.

1. World Health Organization.WHO coronavirus dashboard.https://covid19.who.int/. Accessed April 14 2021.

2. US Department of Health and Human Services.BARDA’s expanding COVID‐19 medical countermeasure portfolio.https://www.medicalcountermeasures.gov/app/barda/coronavirus/COVID19.aspx?filter=vaccine. Accessed April 14 2021.

3. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

4. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

5. Is COVID‐19 infection more severe in kidney transplant recipients?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3